WHO ICTRP trial
A phase IV clinical trial of morinda officinalis oligose capsule
ChiCTR1800014897 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800014897 |
|---|---|
| Public title | A phase IV clinical trial of morinda officinalis oligose capsule |
| Scientific title | A phase IV clinical trial of morinda officinalis oligose capsule |
| Primary sponsor | Peking University Sixth Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | IV (Phase IV study) |
| Countries | China |
| Conditions | Depressive Disorders |
| Interventions | acute phase:morinda officinalis oligose capsule;consolidation phase:morinda officinalis oligose capsule;maintenance phase:maintenance phase |
| Registration date | Feb 13, 2018 |
| Target size | acute phase:2400;consolidation phase:400;maintenance phase:120 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: